- Home
- KFFB vs PASG Comparison
KFFB vs PASG Comparison
Compare KFFB & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFFB
- PASG
- Stock Information
- Founded
- KFFB 2005
- PASG 2017
- Country
- KFFB United States
- PASG United States
- Employees
- KFFB N/A
- PASG N/A
- Industry
- KFFB Savings Institutions
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- KFFB Finance
- PASG Health Care
- Exchange
- KFFB Nasdaq
- PASG Nasdaq
- Market Cap
- KFFB 24.5M
- PASG 20.3M
- IPO Year
- KFFB 2005
- PASG 2020
- Fundamental
- Price
- KFFB $3.25
- PASG $7.44
- Analyst Decision
- KFFB
- PASG Strong Buy
- Analyst Count
- KFFB 0
- PASG 3
- Target Price
- KFFB N/A
- PASG $153.33
- AVG Volume (30 Days)
- KFFB 4.1K
- PASG 98.1K
- Earning Date
- KFFB 09-17-2025
- PASG 08-07-2025
- Dividend Yield
- KFFB N/A
- PASG N/A
- EPS Growth
- KFFB N/A
- PASG N/A
- EPS
- KFFB N/A
- PASG N/A
- Revenue
- KFFB $8,308,000.00
- PASG N/A
- Revenue This Year
- KFFB N/A
- PASG N/A
- Revenue Next Year
- KFFB N/A
- PASG N/A
- P/E Ratio
- KFFB N/A
- PASG N/A
- Revenue Growth
- KFFB 13.79
- PASG N/A
- 52 Week Low
- KFFB $1.96
- PASG $5.12
- 52 Week High
- KFFB $3.62
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- KFFB 69.35
- PASG 53.78
- Support Level
- KFFB $3.19
- PASG $5.12
- Resistance Level
- KFFB $3.31
- PASG $5.99
- Average True Range (ATR)
- KFFB 0.04
- PASG 0.88
- MACD
- KFFB 0.01
- PASG -0.03
- Stochastic Oscillator
- KFFB 85.20
- PASG 58.25
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.